van den Elsen PJ - Search Results

1

T Cell factor 1 represses CD8+ effector T cell formation and function.

Tiemessen MM, Baert MR, Kok L, van Eggermond MC, van den Elsen PJ, Arens R, Staal FJ. Tiemessen MM, et al. Among authors: van den elsen pj, van eggermond mc. J Immunol. 2014 Dec 1;193(11):5480-7. doi: 10.4049/jimmunol.1303417. Epub 2014 Oct 29. J Immunol. 2014. PMID: 25355919

2

A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma.

Holling TM, Bergevoet MW, Wilson L, Van Eggermond MC, Schooten E, Steenbergen RD, Snijders PJ, Jager MJ, Van den Elsen PJ. Holling TM, et al. Among authors: van den elsen pj, van eggermond mc. J Immunol. 2007 Oct 15;179(8):5317-25. doi: 10.4049/jimmunol.179.8.5317. J Immunol. 2007. PMID: 17911618

3

Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region.

van der Stoep N, Quinten E, Alblas G, Plancke A, van Eggermond MC, Holling TM, van den Elsen PJ. van der Stoep N, et al. Among authors: van den elsen pj, van eggermond mc. Mol Immunol. 2007 Mar;44(8):2036-46. doi: 10.1016/j.molimm.2006.09.013. Epub 2006 Oct 25. Mol Immunol. 2007. PMID: 17067677

4

Transcriptional silencing of RFXAP in MHC class II-deficiency.

van Eggermond MC, Tezcan I, Heemskerk MH, van den Elsen PJ. van Eggermond MC, et al. Among authors: van den elsen pj. Mol Immunol. 2008 May;45(10):2920-8. doi: 10.1016/j.molimm.2008.01.026. Epub 2008 Mar 12. Mol Immunol. 2008. PMID: 18336911

5

Epigenetic control in immune function.

van den Elsen PJ, van Eggermond MC, Wierda RJ. van den Elsen PJ, et al. Among authors: van eggermond mc. Adv Exp Med Biol. 2011;711:36-49. doi: 10.1007/978-1-4419-8216-2_4. Adv Exp Med Biol. 2011. PMID: 21627041

6

NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression.

Meissner TB, Liu YJ, Lee KH, Li A, Biswas A, van Eggermond MC, van den Elsen PJ, Kobayashi KS. Meissner TB, et al. Among authors: van den elsen pj, van eggermond mc. J Immunol. 2012 May 15;188(10):4951-8. doi: 10.4049/jimmunol.1103160. Epub 2012 Apr 6. J Immunol. 2012. PMID: 22490869 Free PMC article.

7

Simvastatin reduces CCL2 expression in monocyte-derived cells by induction of a repressive CCL2 chromatin state.

Zanette DL, van Eggermond MC, Haasnoot G, van den Elsen PJ. Zanette DL, et al. Among authors: van den elsen pj, van eggermond mc. Hum Immunol. 2014 Jan;75(1):10-4. doi: 10.1016/j.humimm.2013.09.016. Epub 2013 Oct 14. Hum Immunol. 2014. PMID: 24135266

8

A role for KMT1c in monocyte to dendritic cell differentiation: Epigenetic regulation of monocyte differentiation.

Wierda RJ, Goedhart M, van Eggermond MC, Muggen AF, Miggelbrink XM, Geutskens SB, van Zwet E, Haasnoot GW, van den Elsen PJ. Wierda RJ, et al. Among authors: van zwet e, van den elsen pj, van eggermond mc. Hum Immunol. 2015 Jun;76(6):431-7. doi: 10.1016/j.humimm.2015.03.017. Epub 2015 Apr 3. Hum Immunol. 2015. PMID: 25843229

9

TCR V alpha- and V beta-gene segment use in T-cell subcultures derived from a type-III bare lymphocyte syndrome patient deficient in MHC class-II expression.

Lambert M, Van Eggermond M, Mascart F, Dupont E, Van den Elsen P. Lambert M, et al. Dev Immunol. 1992;2(3):227-36. doi: 10.1155/1992/29814. Dev Immunol. 1992. PMID: 1320968 Free PMC article.

10

Lymphokine gene transcription in CD4+CD8- T cells of a type III bare lymphocyte syndrome patient.

Lambert M, van Eggermond M, van den Elsen P. Lambert M, et al. Hum Immunol. 1993 Jul;37(3):143-8. doi: 10.1016/0198-8859(93)90179-5. Hum Immunol. 1993. PMID: 8244777

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page